Prolacta Bioscience in the news
Human milk-based nutritional products
Tamtam found 20 recent articles about Prolacta Bioscience.
- Human Milk Bank Management Market Poised for Significant Expansion |• Medolac Laboratories • Prolacta Bioscience
The Human Milk Bank Management Market is projected to expand notably, with key players like Prolacta Bioscience involved, driven by technological and regulatory developments across global regions.
- Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
In 2025, most U.S. top-level NICUs used Prolacta's 100% breastmilk-based fortifiers and formulas, improving survival and development in premature infants.
- Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
In 2025, most U.S. high-level NICUs used Prolacta's 100% breastmilk-based fortifiers and formulas, improving survival and development in extremely premature infants by avoiding cow milk and synthetic ingredients.
- Majority of U.S. Level III & IV NICUs in 2025 Used Prolacta's 100% Breastmilk-Based Fortifiers & Formulas to Improve Outcomes for Premature Infants
In 2025, most U.S. top-level NICUs used Prolacta's 100% breastmilk-based fortifiers and formulas, improving survival and development for extremely premature infants by avoiding cow milk and synthetic ingredients.
- Prolacta Bioscience: Safe Nutrition For Premature Infants
Proper nutrition in the early days is crucial for the care and progress of premature infants, as highlighted during Prematurity Awareness Month.
- Most Comprehensive Meta-Analysis to Date Finds an Exclusive Human Milk Diet Is Associated With Up to 49% Lower Risk of Necrotizing Enterocolitis in Premature Infants
A comprehensive meta-analysis shows that Prolacta Bioscience's human milk-based fortifiers significantly reduce the risk of necrotizing enterocolitis in very low birth weight premature infants.
- Prolacta Bioscience - 2025 Funding Rounds & List of Investors
Prolacta Bioscience raised $98.7M in 10 rounds, with the largest $35M Series E round in 2016 led by EW Healthcare Partners.
- First for Japan: Prolacta Bioscience’s human milk-based fortifiers approved for clinical trial on premature infants
Prolacta Bioscience is conducting a clinical trial in Japan to approve its human milk-based nutritional fortifiers as pharmaceutical drugs for premature infants, aiming to replace cow milk-based fortifiers.
- Prolacta Bioscience Approaches 20 Years Nourishing Extremely Premature Babies as #1 Hospital Provider of Human Milk-Based Fortifiers and Formulas
Prolacta Bioscience has pioneered 100% human milk-based nutritional products for nearly 20 years, improving outcomes for extremely premature infants by reducing risks linked to cow milk-based fortifiers.
- NICU Awareness Month Milestone: 125,000 Preemies Helped by Prolacta Bioscience's 100% Breast Milk-Based Nutrition
Prolacta Bioscience's 100% human milk-based nutrition products have supported over 125,000 premature infants, reducing complications and improving survival and development.
- Study: Despite Being Born Earlier and Weighing Less, Preemies Fed Prolacta's Exclusive Human Milk Diet Had Lower Motor Skill Disability Risk by Age 3 Compared to Larger Preemies Fed Cow Milk-Based Products
Premature infants fed Prolacta's exclusive human milk diet showed significantly better motor skill development by age 3 than larger preemies fed cow milk-based products.
- Improved Survival and Growth While Cutting Malnutrition for Premature Infants Fed Human Milk-Based Fortifiers at Sydney Hospital
A Sydney hospital study found that Prolacta's exclusive human milk diet fortifiers improve survival, growth, and reduce malnutrition in extremely low birth weight infants compared to cow milk-based fortifiers.
- Prolacta Bioscience is making sure premature infants get the nutrition they need
Prolacta Bioscience ensures premature infants receive essential nutrition.
- Parents of preemies need to know that there are nutritional options in the NICU
Prolacta Bioscience's 100% human milk-based fortifiers support the health and development of very premature infants in the NICU, helping them thrive and leave the hospital sooner.
- FDA Approves First Human Milk-Based Fortifier for Term Infants
FDA approved Surgifort, a human milk-based fortifier for term infants recovering from gastroschisis surgery, supporting faster growth and recovery.
- Prolacta Bioscience Neonatologist Dr. Erin Hamilton Spence Earns Breastfeeding and Lactation Medicine Certification Held by Fewer Than 100 North American Physicians
Dr. Erin Hamilton Spence earned a rare breastfeeding and lactation medicine certification, enhancing Prolacta's efforts to ensure safe, high-quality human milk products for premature infants.
- Prolacta Bioscience Neonatologist Dr. Erin Hamilton Spence Earns Breastfeeding and Lactation Medicine Certification Held by Fewer Than 100 North American Physicians
Dr. Erin Hamilton Spence earned a rare breastfeeding and lactation medicine certification, enhancing Prolacta's leadership in safe, high-quality human milk-based nutrition for vulnerable infants.
- Prolacta Bioscience Neonatologist Dr. Erin Hamilton Spence Earns Breastfeeding and Lactation Medicine Certification Held by Fewer Than 100 North American Physicians
Dr. Erin Hamilton Spence earned a rare breastfeeding and lactation medicine certification, enhancing Prolacta's expertise in ensuring safe, high-quality human milk products for premature infants.
- FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis
FDA approved Surgifort®, a human milk-based fortifier for term infants recovering from gastroschisis surgery, to support growth and recovery.
- FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis
FDA approved Surgifort, a human milk-based fortifier by Prolacta, to support growth in term infants after gastroschisis surgery.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Prolacta Bioscience?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies